Neuroendocrinology News

A 39-year-old Vietnamese woman was referred to the endocrine clinic for the evaluation of a toxic multinodular goiter. The goiter was found after a routine physical exam by her new primary care physician.

The Food and Drug Administration granted diazoxide choline, studied previously for high triglycerides, orphan drug status for the treatment of Prader-Willi syndrome.

Lower cognitive function in children with type 1 diabetes could be linked to abnormal anatomy in the hippocampus, suggesting a potential neural substrate for mild deficits, according to data presented at the Pediatric Academic Societies and Asian Society for Pediatric Research joint meeting in Vancouver, British Columbia.

Patients with inadequately controlled acromegaly on first-generation somatostatin analogues could see improvement with pasireotide long-acting release, based on results from a phase 3 trial presented at the 16th European Congress of Endocrinology.

Severity and duration of type 2 diabetes could contribute to brain degeneration, but not small vessel ischemic disease, according to research published in Radiology.

Three recently published studies examined the protective effects of estrogen in older men and women.

In infants born before 28 weeks of gestational age, neonatal thyroid hormone treatment did not appear to have an effect on neurodevelopment, according to study findings published in Thyroid.

Adults with low blood glucose were more likely to act aggressively toward their spouses, according to findings published in the Proceeding of the National Academy of Sciences.

Overweight and obese adolescents have a lower visceral fat mass than their adult counterparts, but they are more insulin-resistant than sex- and BMI-matched adults, according to recent findings published in Obesity.

Endocrine Today reports on five interventions that reduced mortality, comorbid illness, symptoms and critical outcomes in adult patients being treated for type 2 diabetes.